04/21/2026
GLP-1 resistance is partly written in your DNA. A 2026 study in Genome Medicine identified variants in the PAM gene that reduce response to GLP-1 therapy by ~44% — meaning some people are spending thousands on a drug their biology was never built to answer.
The era of one-size-fits-all medicine is ending. Whole genome sequencing is under $1,000. Longevity AI interprets the data in real time. And 2026 is the year genomic medicine goes mainstream.
Before you spend on trial-and-error, ask one question: do you actually understand your genome?